American Thoracic Society. Single breath carbon monoxide diffusing capacity (transfer factor): recommendations for a standard technique. Am Rev Respir Dis1987;136:1299–1307.
2.
American Thoracic Society. Single breath carbon monoxide diffusing capacity (transfer factor): recommendations for a standard technique—1995 update. Am J Respir Crit Care Med1995;152:2185–2198.
3.
WeinbergerSE, JohnsonTS, WeissST. Clinical significance of pulmonary function tests: use and interpretation of the single-breath diffusing capacity. Chest1980;78:483–488
4.
EplerGR, SaberFA, GaenslerEA. Determination of severe impairment (disability) in interstitial lung disease. Am Rev Respir Dis1980;121:647–659.
5.
OgilvieC.The single-breath carbon monoxide transfer test 25 years on: a reappraisal. 2. Clinical considerations (editorial). Thorax1983;38:5–9.
6.
MorrisAH, KannerRE, CrapoRO, GardnerRM. Clinical pulmonary function testing: a manual of uniform laboratory procedures, 2nd ed. Salt Lake City: Intermountain Thoracic Society, 1984.
7.
KnudsonRJ, KaltenbornW, BurrowsB.Single breath carbon monoxide transfer factor in different forms of chronic airflow obstruction in a general population sample. Thorax1990;45:514–519.
8.
LightRW, GeorgeRB. Serial pulmonary function in patients with acute heart failure. Arch Intern Med1983;143:429–43.
9.
GibsonGJ, EdmundsJP, HughesGRV. Diaphragm function and lung involvement in systemic lupus erythematosus. Am J Med1977;63:926–932.
10.
GrossM, EsterlyJR, EarleRH. Pulmonary alterations in systemic lupus erythematosus. Am Rev Respir Dis1972;105:572–577.
11.
FrankST, WegJG, HarkeroadLE, FitchRF. Pulmonary dysfunction in rheumatoid disease. Chest1973;63:27–34.
12.
ComisRL. Bleomycin pulmonary toxicity: current status and future directions. Sem Oncol1992;19(Suppl 5):64–70.
13.
AbrattRP, WilcoxPA. The effect of irradiation on lung function and perfusion in patients with lung cancer. Internat J Radiol Oncol Biol Phys1995;31:915–919.
14.
NganHY, LiangRH, LamWK, ChanTK. Pulmonary toxicity in patients with non-Hodgkins lymphoma treated with bleomycin-containing combination chemotherapy. Cancer Chemother & Pharmacol1993;32:407–409.
MitchellDM, FlemingJ, PnichingAJ, HarrisJR, MossFM, VealeD, ShawRJ. Pulmonary function in human immunodeficiency virus infection; a prospective 18-month study of serial lung function in 474 patients. Am Rev Respir Dis1992;146:745–751.
17.
OwensGR, RogersRM, PennockBE, LevinD.The diffusing capacity as a predictor of arterial oxygen desaturation during exercise in patients with chronic obstructive pulmonary disease. N Engl J Med1984;310:1218–1221.
18.
NordenfeltI, SvenssonG.The transfer factor (diffusing capacity) as a predictor of hypoxaemia during exercise in restrictive and chronic obstructive pulmonary disease. Clin Physiol1987;7:423–430.
19.
SansoresRH, ParePD, AbboudRT. Acute effect of cigarette smoking on the carbon monoxide diffusing capacity of the lung. Am Rev Respir Dis1992;146(4):951–958.
20.
CotesJE. Lung function: assessment and application in medicine, 4th ed. Oxford: Blackwell Scientific Publications, 1979:203,329.
21.
SmithTC, RankinJ.Pulmonary diffusing capacity and the capillary bed during Valsalva and Müller maneuvers. J Appl Physiol1969;27:826–833.
22.
PeavyHH, SummerWR, GurtnerG.The effects of acute ethanol ingestion on pulmonary diffusing capacity. Chest1977;4:488–492.
23.
LawsonWH. Effect of drugs, hypoxia, and ventilatory maneuvers on lung diffusion for CO in man. J Appl Physiol1972;32:788–794.
24.
MilneJA, MillsRJ, CouttsJRT, MacNaughtonMC, MoranF, PackAI. The effect of human pregnancy on the pulmonary transfer factor for carbon monoxide as measured by the single breath method. Clin Sci Mol Med1977;53:271–276.
25.
SansoresR, GibsonN, AbboudR.Variation of pulmonary CO diffusing capacity (DLCO) during the menstrual cycle (abstract). Am Rev Respir Dis1991;143(4, Part 2):A759.
26.
ClausenJ, CrapoR, GardnerRM. Interlaboratory comparisons of pulmonary function testing (abstract). Am Rev Respir Dis1984;129(4, Part 2):A37.
27.
WangerJ, IrvinC.Comparability of pulmonary results from 13 laboratories in a metropolitan area. Respir Care1991;36:1375–1382.
28.
HathawayEH, TashkinDP, SimmonsMS. Intra-individual variability in serial measurements of DLCO and alveolar volume over one year in eight healthy subjects using three independent systems. Am Rev Respir Dis1989;140:1818–1822.
29.
CrapoRO, GardnerRM. DLCO reference equations: a perspective (editorial). Am Rev Respir Dis1986;134:856.
30.
American Thoracic Society. Quality assurance in pulmonary function laboratories. (position paper)Am Rev Respir Dis1986;134:625–627.
31.
American Thoracic Society. Pulmonary function laboratory personnel qualifications. Am Rev Respir Dis1986;134(3):623–624.
32.
American Thoracic Society. Pulmonary function laboratory management. In: WangerJ, CrapoRO, IrvinCG, editors. American Thoracic Society1998.
33.
TablanOC, WilliamsWW, MartoneWJ. Infection control in pulmonary function laboratories. Infect Control1985;6:442–444.
34.
GarnerJS, Hospital Infection Control Practices Advisory Committee, Centers for Disease Control and Prevention. Guidelines for Isolation Precautions in Hospitals. Atlanta GA: Centers for Disease Control and Prevention, 1996. www.cdc.gov
35.
Centers for Disease Control & Prevention. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities. Washington DC: Federal Register1994;59(208), Friday Oct 28, 1994: 54242–54303. www.cdc.gov